Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 32.1%
Negative

Neutral
Business Wire
16 hours ago
Zoetis Announces Health Canada Approval of Lenivia® (izenivetmab injection) for Alleviation of Osteoarthritis (OA) Pain in Dogs
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Lenivia approval by Health Canada marks major milestone in the company's continued innovation for canine OA pain.
Zoetis Announces Health Canada Approval of Lenivia® (izenivetmab injection) for Alleviation of Osteoarthritis (OA) Pain in Dogs
Positive
Zacks Investment Research
yesterday
Why Zoetis (ZTS) is Poised to Beat Earnings Estimates Again
Zoetis (ZTS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Zoetis (ZTS) is Poised to Beat Earnings Estimates Again
Positive
Zacks Investment Research
2 days ago
Zoetis Gains CVMP Backing for Lenivia, Eyes EU Approval in Dog OA Pain
ZTS secures CVMP's positive opinion recommending the approval of Lenivia, a long-acting OA pain therapy for dogs, with the final decision expected in late 2025.
Zoetis Gains CVMP Backing for Lenivia, Eyes EU Approval in Dog OA Pain
Neutral
Business Wire
5 days ago
Zoetis Receives Positive Opinion from CVMP for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--If approved, Lenivia will be a new antibody therapy that reduces OA pain in dogs for three months with one injection.
Zoetis Receives Positive Opinion from CVMP for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs
Neutral
Business Wire
6 days ago
Zoetis Declares Fourth Quarter 2025 Dividend
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.50 per share for the fourth quarter of 2025. The dividend will be paid on Tuesday, December 2, 2025, to all holders of record of the Company's common stock as of the close of business on Friday, October 31, 2025. About Zoetis As the world's leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After i.
Zoetis Declares Fourth Quarter 2025 Dividend
Positive
The Motley Fool
7 days ago
2 Magnificent Dividend Stocks to Buy Now and Hold Forever
Few stocks are worth holding onto forever. Those that do tend to have certain traits, including a strong position in an industry with excellent growth prospects and strong, consistent financial results.
2 Magnificent Dividend Stocks to Buy Now and Hold Forever
Positive
The Motley Fool
10 days ago
My 2 Favorite Stocks to Buy Right Now
The S&P 500 continues to advance to new all-time highs, delivering total returns of 15.2% so far in 2025. However, much of this run stems from the "Magnificent Seven" and other massive technology stocks that have an outsize influence on the index.
My 2 Favorite Stocks to Buy Right Now
Positive
Seeking Alpha
12 days ago
Top 50 High-Quality Dividend Growth Stocks For October 2025
I track a universe of 50 high-quality dividend growth stocks to identify opportune investments based on valuation and future return potential. As of October 2, 2025, 22 stocks offer attractive future return estimates of at least 10%, with 15 appearing potentially undervalued by my Free Cash Flow model. Top-ranked stocks include MKTX, RMD, MPWR, RACE, and MSCI, each offering strong projected returns driven by yield, valuation upside, and EPS growth.
Top 50 High-Quality Dividend Growth Stocks For October 2025
Positive
The Motley Fool
13 days ago
Zoetis: A Solid Investment in the Growing Pet Medicine Market?
Explore the exciting world of Zoetis (ZTS -0.31%) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!
Zoetis: A Solid Investment in the Growing Pet Medicine Market?
Positive
Seeking Alpha
14 days ago
Top 15 High-Growth Dividend Stocks For October 2025
The Top 15 High-Growth Dividend Stock list for October 2025 targets a 12% long-term return, despite underperforming SPY and VIG in September. These 15 stocks offer a 1.4% average yield and have grown dividends at 19.1% annually over five years, with many trading at significant discounts. Recent changes include six new additions, with expected long-term CAGRs near 20% based on dividend yield theory and valuation metrics.
Top 15 High-Growth Dividend Stocks For October 2025